[1,3-Bis(2,6-diisopropylphenyl)imidazolidin-2-ylidene](chloro)silver, CAS [[873297-20-2]]

Artikelnummer: TGM-T212772
Artikelname: [1,3-Bis(2,6-diisopropylphenyl)imidazolidin-2-ylidene](chloro)silver, CAS [[873297-20-2]]
Artikelnummer: TGM-T212772
Hersteller Artikelnummer: T212772
Alternativnummer: TGM-T212772-1MG,TGM-T212772-5MG,TGM-T212772-10MG,TGM-T212772-25MG,TGM-T212772-50MG
Hersteller: TargetMol
Kategorie: Biochemikalien
[1,3-Bis(2,6-diisopropylphenyl)imidazolidin-2-ylidene](chloro)silver is a silver-N-heterocyclic carbene (Silver-NHC) complex with potent anticancer activity. It effectively inhibits the proliferation of various cancer cell lines by inducing apoptosis. Distinct from classical pathways, its mechanism is independent of caspase activation. Instead, it triggers the release of mitochondrial Apoptosis-Inducing Factor (AIF), which translocates to the nucleus to cause chromatin condensation and large-scale DNA fragmentation. As a novel organometallic anticancer lead, SIPrAgCl holds significant promise for research aimed at overcoming conventional drug resistance in tumors.
Molekulargewicht: 533.93
Reinheit: 99.97%
CAS Nummer: [873297-20-2]
Formel: C27H38AgClN2
Target-Kategorie: Apoptosis
T212772